Subscribe to RSS
DOI: 10.1055/s-0039-1694968
Seizure Risk following Open and Expanded Endoscopic Endonasal Approaches for Intradural Skull Base Tumors
Funding This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors.![](https://www.thieme-connect.de/media/jnlsb/202006/lookinside/thumbnails/10-1055-s-0039-1694968_190160-1.jpg)
Abstract
Objectives The incidence of seizures following a craniotomy for tumor removal varies between 15 and 20%. There has been increased use of endoscopic endonasal approaches (EEAs) for a variety of intracranial lesions due to its more direct approach to these pathologies. However, the incidence of postoperative seizures in this population is not well described.
Methods This is a single-center, retrospective review of consecutive patients undergoing EEA or open craniotomy for resection of a cranial base tumor between July 2007 and June 2014. Patients were included if they underwent an EEA for an intradural skull base lesion. Positive cases were defined by electroencephalograms and clinical findings. Patients who underwent a craniotomy to remove extra-axial skull base tumors were analyzed in the same fashion.
Results Of the 577 patients treated with an EEA for intradural tumors, 4 experienced a postoperative seizure (incidence 0.7%, 95% confidence interval [CI]: 0.002–0.02). Over the same period, 481 patients underwent a craniotomy for a skull base lesion of which 27 (5.3%, 95% CI: 0.03–0.08) experienced a seizure after surgery. The odds ratio for EEA was 0.13 (95% CI: 0.05–0.35). Both populations were different in terms of age, gender, tumor histology, and location.
Conclusion This study is the largest series looking at seizure incidence after EEA for intracranial lesions. Seizures are a rare occurrence following uncomplicated endonasal approaches. This must be tempered by selection bias, as there are inherent differences in which patients are treated with either approach that influence the likelihood of seizures.
Competing Interests
The authors have no personal or institutional interest with regard to the authorship and/or publication of this article.
Authors' Contribution
P.G., J.C., and E.G. were involved in the design and conception of this article. E.G. and H.A. performed the literature search. H.A., N.K., E.G., and A.N. performed the chart review. E.G. compiled the primary article. F.A. compiled the tables. P.G., J.C., E.G., C.S., J.F.M., and E.W. critically revised the article. All authors have approved the article as it is written.
Data Sharing
All data pertaining to this research article are included within the article as written.
Publication History
Received: 10 May 2019
Accepted: 03 July 2019
Article published online:
27 August 2019
© 2020. Thieme. All rights reserved.
Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany
-
References
- 1 Dasenbrock HH, Yan SC, Smith TR. et al. Readmission after craniotomy for tumor: a National Surgical Quality Improvement Program Analysis. Neurosurgery 2017; 80 (04) 551-562
- 2 Pulman J, Greenhalgh J, Marson AG. Antiepileptic drugs as prophylaxis for post-craniotomy seizures. Cochrane Database Syst Rev 2013; (02) CD007286
- 3 Lockney DT, Vaziri S, Walch F. et al. Prophylactic antiepileptic drug use in patients with brain tumors undergoing craniotomy. World Neurosurg 2017; 98: 28-33
- 4 Greenhalgh J, Weston J, Dundar Y, Nevitt SJ, Marson AG. Antiepileptic drugs as prophylaxis for postcraniotomy seizures. Cochrane Database Syst Rev 2018; 5: CD007286
- 5 Wu AS, Trinh VT, Suki D. et al. A prospective randomized trial of perioperative seizure prophylaxis in patients with intraparenchymal brain tumors. J Neurosurg 2013; 118 (04) 873-883
- 6 Lai L, Morgan MK, Trooboff S, Harvey RJ. A systematic review of published evidence on expanded endoscopic endonasal skull base surgery and the risk of postoperative seizure. J Clin Neurosci 2013; 20 (02) 197-203
- 7 Bander ED, Singh H, Ogilvie CB. et al. Endoscopic endonasal versus transcranial approach to tuberculum sellae and planum sphenoidale meningiomas in a similar cohort of patients. J Neurosurg 2018; 128 (01) 40-48
- 8 Englot DJ, Magill ST, Han SJ, Chang EF, Berger MS, McDermott MW. Seizures in supratentorial meningioma: a systematic review and meta-analysis. J Neurosurg 2016; 124 (06) 1552-1561
- 9 Goldschmidt E, Hem S, Ajler P. et al. A new model for dura mater healing: human dural fibroblast culture. Neurol Res 2013; 35 (03) 300-307
- 10 Kassam AB, Prevedello DM, Carrau RL. et al. Endoscopic endonasal skull base surgery: analysis of complications in the authors' initial 800 patients. J Neurosurg 2011; 114 (06) 1544-1568
- 11 Koutourousiou M, Fernandez-Miranda JC, Stefko ST, Wang EW, Snyderman CH, Gardner PA. Endoscopic endonasal surgery for suprasellar meningiomas: experience with 75 patients. J Neurosurg 2014; 120 (06) 1326-1339
- 12 Rao YJ, Hassanzadeh C, Fischer-Valuck B. et al. Patterns of care and treatment outcomes of patients with craniopharyngioma in the national cancer database. J Neurooncol 2017; 132 (01) 109-117
- 13 Miziak B, Borowicz-Reutt K, Rola R, Blaszczyk B, Czuczwar M, Czuczwar SJ. The prophylactic use of antiepileptic drugs in patients scheduled for neurosurgery. Curr Pharm Des 2017; 23 (42) 6411-6427
- 14 Weston J, Greenhalgh J, Marson AG. Antiepileptic drugs as prophylaxis for post-craniotomy seizures. Cochrane Database Syst Rev 2015; (03) CD007286
- 15 Islim AI, McKeever S, Kusu-Orkar T-E, Jenkinson MD. The role of prophylactic antiepileptic drugs for seizure prophylaxis in meningioma surgery: a systematic review. J Clin Neurosci 2017; 43: 47-53
- 16 Ambrosi M, Orsini A, Verrotti A, Striano P. Medical management for neurosurgical related seizures. Expert Opin Pharmacother 2017; 18 (14) 1491-1498
- 17 Hess K, Spille D, Adeli A. et al. Brain invasion and the risk of seizures in patients with meningioma. J Neurosurg 130 (03) 789-796
- 18 Margalit N, Shahar T, Barkay G. et al. Tuberculum sellae meningiomas: surgical technique, visual outcome, and prognostic factors in 51 cases. J Neurol Surg B Skull Base 2013; 74 (04) 247-258
- 19 Raza SM, Garzon-Muvdi T, Gallia GL, Tamargo RJ. Craniofacial resection of midline anterior skull base malignancies: a reassessment of outcomes in the modern era. World Neurosurg 2012; 78 (1-2): 128-136
- 20 Seyedi JF, Pedersen CB, Poulsen FR. Risk of seizures before and after neurosurgical treatment of intracranial meningiomas. Clin Neurol Neurosurg 2018; 165: 60-66
- 21 Batra PS, Citardi MJ, Worley S, Lee J, Lanza DC. Resection of anterior skull base tumors: comparison of combined traditional and endoscopic techniques. Am J Rhinol 2005; 19 (05) 521-528
- 22 Cohen MA, Liang J, Cohen IJ, Grady MS, O'Malley Jr BW, Newman JG. Endoscopic resection of advanced anterior skull base lesions: oncologically safe?. ORL J Otorhinolaryngol Relat Spec 2009; 71 (03) 123-128
- 23 Lin Y, Hansen D, Sayama C, Pan I, Lam S. Transfrontal and Transsphenoidal Approaches to Pediatric Craniopharyngioma: A National Perspective. Pediatr Neurosurg 2017; 52 (03) 155-160
- 24 Komotar RJ, Starke RM, Raper DM, Anand VK, Schwartz TH. Endoscopic endonasal compared with microscopic transsphenoidal and open transcranial resection of craniopharyngiomas. World Neurosurg 2012; 77 (02) 329-341
- 25 de Almeida JR, Carvalho F, Vaz Guimaraes Filho F. et al. Comparison of endoscopic endonasal and bifrontal craniotomy approaches for olfactory groove meningiomas: a matched pair analysis of outcomes and frontal lobe changes on MRI. J Clin Neurosci 2015; 22 (11) 1733-1741
- 26 Jenssen S, Potolicchio S, Sekhar L. Do skull base lesions and their surgical treatment cause epileptic seizures?. Clin Neurol Neurosurg 2007; 109 (05) 406-408
- 27 Carta F, Kania R, Sauvagate E. et al. Endoscopy skull-base resection for ethmoid adenocarcinoma and olfactory neuroblastoma. Rhinology 2011; 49 (01) 74-79